Ibio Cash And Cash Equivalents Changes vs Change To Account Receivables Analysis
| IBIO Stock | USD 2.54 0.12 4.51% |
Ibio financial indicator trend analysis is infinitely more than just investigating Ibio Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ibio Inc is a good investment. Please check the relationship between Ibio Cash And Cash Equivalents Changes and its Change To Account Receivables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Cash And Cash Equivalents Changes vs Change To Account Receivables
Cash And Cash Equivalents Changes vs Change To Account Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ibio Inc Cash And Cash Equivalents Changes account and Change To Account Receivables. At this time, the significance of the direction appears to have no relationship.
The correlation between Ibio's Cash And Cash Equivalents Changes and Change To Account Receivables is 0.04. Overlapping area represents the amount of variation of Cash And Cash Equivalents Changes that can explain the historical movement of Change To Account Receivables in the same time period over historical financial statements of Ibio Inc, assuming nothing else is changed. The correlation between historical values of Ibio's Cash And Cash Equivalents Changes and Change To Account Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Cash Equivalents Changes of Ibio Inc are associated (or correlated) with its Change To Account Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Account Receivables has no effect on the direction of Cash And Cash Equivalents Changes i.e., Ibio's Cash And Cash Equivalents Changes and Change To Account Receivables go up and down completely randomly.
Correlation Coefficient | 0.04 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Cash And Cash Equivalents Changes
Change To Account Receivables
Most indicators from Ibio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ibio Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Ibio's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 12th of December 2024, Enterprise Value Over EBITDA is likely to grow to 0.15, while Selling General Administrative is likely to drop about 11.2 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 2.2M | 50K | 225K | 213.8K | Total Revenue | 2.4M | 50K | 225K | 213.8K |
Ibio fundamental ratios Correlations
Click cells to compare fundamentals
Ibio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ibio fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 94.2M | 147.0M | 99.4M | 41.2M | 28.7M | 38.8M | |
| Other Current Liab | 1.1M | 3.3M | 3.5M | 5.9M | 2.3M | 1.9M | |
| Total Current Liabilities | 5.2M | 6.6M | 30.4M | 21.6M | 3.8M | 6.2M | |
| Total Stockholder Equity | 56.6M | 108.6M | 63.5M | 15.4M | 21.3M | 20.0M | |
| Property Plant And Equipment Net | 31.3M | 34.7M | 41.8M | 7.6M | 6.4M | 6.1M | |
| Net Debt | (22.2M) | (44.7M) | 5.1M | 12.8M | (9.8M) | (9.3M) | |
| Retained Earnings | (150.4M) | (173.6M) | (223.9M) | (288.9M) | (313.8M) | (298.2M) | |
| Accounts Payable | 1.8M | 2.3M | 4.3M | 1.8M | 358K | 340.1K | |
| Cash | 55.1M | 77.4M | 22.7M | 4.3M | 14.2M | 15.5M | |
| Non Current Assets Total | 32.4M | 42.4M | 54.3M | 14.9M | 13.1M | 17.9M | |
| Cash And Short Term Investments | 55.1M | 97.0M | 33.5M | 4.3M | 14.2M | 17.3M | |
| Net Receivables | 5.6M | 5.5M | 6.1M | 204K | 713K | 1.3M | |
| Common Stock Shares Outstanding | 125.6K | 391.3K | 436.1K | 612.3K | 3.8M | 4.0M | |
| Liabilities And Stockholders Equity | 94.2M | 147.0M | 99.4M | 41.2M | 28.7M | 38.8M | |
| Non Current Liabilities Total | 32.3M | 31.8M | 5.5M | 4.2M | 3.6M | 3.4M | |
| Other Current Assets | 214K | 2.1M | 1.5M | 21.8M | 749K | 711.6K | |
| Other Stockholder Equity | 206.9M | 282.1M | 287.6M | 304.3M | 335.2M | 351.9M | |
| Total Liab | 37.6M | 38.4M | 35.9M | 25.8M | 7.4M | 7.0M | |
| Property Plant And Equipment Gross | 31.3M | 34.7M | 45.3M | 8.2M | 7.9M | 13.9M | |
| Total Current Assets | 61.7M | 104.6M | 45.1M | 26.3M | 15.7M | 20.9M | |
| Intangible Assets | 1.1M | 952K | 4.9M | 5.4M | 5.4M | 3.2M | |
| Common Stock | 16K | 20K | 140K | 217K | 9K | 8.6K | |
| Property Plant Equipment | 3.7M | 34.7M | 41.8M | 7.6M | 8.7M | 13.8M | |
| Common Stock Total Equity | 16K | 20K | 140K | 217K | 249.6K | 262.0K | |
| Inventory | 798K | 27K | 3.9M | 21.1M | 24.3M | 25.5M | |
| Net Tangible Assets | 56.6M | 107.6M | 58.6M | 10.0M | 11.5M | 10.9M | |
| Short Term Debt | 562K | 1.3M | 22.3M | 13.6M | 953K | 905.4K | |
| Accumulated Other Comprehensive Income | (31K) | (33K) | (63K) | (213K) | (191.7K) | (182.1K) | |
| Short Long Term Debt Total | 32.9M | 32.7M | 27.8M | 17.1M | 4.5M | 4.2M | |
| Current Deferred Revenue | 1.8M | 423K | 100K | 4.2M | 200K | 190K | |
| Capital Lease Obligations | 32.3M | 32.1M | 5.6M | 4.1M | 3.5M | 3.3M |
Pair Trading with Ibio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ibio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will appreciate offsetting losses from the drop in the long position's value.Moving together with Ibio Stock
Moving against Ibio Stock
| 0.57 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.51 | ERNA | Eterna Therapeutics | PairCorr |
| 0.5 | SLS | Sellas Life Sciences | PairCorr |
| 0.39 | VALN | Valneva SE ADR | PairCorr |
| 0.31 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to Ibio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ibio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ibio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ibio Inc to buy it.
The correlation of Ibio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ibio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ibio Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ibio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.03) | Revenue Per Share 0.059 | Quarterly Revenue Growth (0.88) | Return On Assets (0.30) | Return On Equity (0.84) |
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.